Russia’s Sechenov University says it has completed clinical trials of world’s first COVID-19 vaccine on volunteers at Sechenov First Moscow State Medical University.
The Director of the Institute for Translational Medicine and Biotechnology, Vadim Tarasov said the first group of volunteers who participated in the study would be discharged on Wednesday and the second on July 20, 2020.
He said “Sechenov University in a pandemic situation acted not only as an educational institution but also as a scientific and technological research centre that is able to participate in the creation of such important and complex products as drugs.
“We worked with this vaccine, starting with preclinical studies and protocol development, and clinical trials are currently underway”, Tarasov added.
According to Vadim, the vaccine would be tested on volunteers at the Sechenov First Moscow State Medical University.
Director of the Institute of Medical Parasitology of the University, Alexander Lukashev noted that the safety of the vaccine is confirmed.
It corresponds to the safety of those vaccines that are currently on the market.
He said the objective of stage of the trials was to test the vaccine’s safety for, human health, which was successfully done
He said that further plans on vaccine development are being determined by the developers, including the complexity of the epidemiological situation with the virus and the possibility of scaling up production.
More than a hundred vaccines against the novel coronavirus are currently under development or trials, globally.
The coronavirus has infected more than 12 million people around the world, till now.